how is hers still selling compounded semaglutide What semaglutide? All you need to know about the weight loss drugs Hims & is Shares of Hims & Hers

Building this habit eliminates the "I just set it down for a second" problem that leads to hours-long counter exposure

Switching studies provide partial insight Several studies have examined one-directional switching, primarily from semaglutide to tirzepatide

You are a role model for this approach

We help patients with: Portion control Meal planning Healthy food choices Emotional eating Dining out strategies Healthy habit development Long-term maintenance planning We focus on realistic, maintainable changes that support lifelong health rather than short-term dieting

Your body needs time to adjustrushing this process almost guarantees side effects

A SURMOUNT-1 post-hoc analysis of 2,542 women, published in Obesity in 2025, found perimenopausal women on tirzepatide lost 23% of body weight against 3% on placebo, almost identical to the premenopausal result